Multiple studies have indicated that increased FGF23 levels are correlated with cardiovascular disorders (such as heart failure, atrial fibrillation, myocardial infarction and stroke) and an increased risk of both cardiovascular and non-cardiovascular mortality [5,6,12,13,14]. This evidence concerns the gene FGF23 and atrial fibrillation.